Age- and sex-related expression and activity of carboxylesterase 1 and 2 in mouse and human liver.
Carboxylesterase (CES) 1 and CES2 are two major hepatic hydrolases responsible for the metabolism of numerous endogenous and exogenous compounds. In this study, age- and sex-dependent expression and activity of CES1 and CES2 were investigated using both animal models and individual human liver s9 samples. The expression and activity of mouse CES1 (mCES1) and mCES2 in the liver were markedly lower in newborns relative to adults and increased gradually with age, approximating levels of adult animals by age 2 to 4 weeks. Likewise, the average human CES1 (hCES1) expression in the subjects <1 year of age was significantly lower than that of pooled samples. In particular, hCES1 expression in the 13-day and 1-month-old subjects was just 20.3 and 11.1%, respectively, of the pooled sample values. In addition, the subjects <1 year of age exhibited a trend suggestive of low hCES2 expression, but this difference failed to reach statistical significance because of large interindividual variability. The expression and activity of mCES1 and mCES2 were not significantly altered after the animals were treated with human growth hormone, indicating growth hormone may not be associated with the low level of CES expression during early developmental stages. No significant differences of the expression and activity of mCES1 and mCES2 were observed between sexually mature male and female mice. In conclusion, the expression and activity of CES1 and CES2 are age-related but independent of growth hormone level. Sex seems to be an unlikely factor contributing to the regulation of CES1 and CES2.
Zhu
Hao-Jie
HJ
Department of Pharmaceutical and Biomedical Sciences, Medical University of South Carolina, 73 Ashley Avenue, Charleston, SC 29425, USA.
Appel
David I
DI
Jiang
Yan
Y
Markowitz
John S
JS
D000293:Adolescent; D000328:Adult; D000368:Aged; D000375:Aging / Q000502:physiology*; D000818:Animals; D000972:Antineoplastic Agents, Phytogenic / Q000378:metabolism; D015153:Blotting, Western; D002166:Camptothecin / Q000031:analogs & derivatives / Q000378:metabolism; D043182:Carboxylesterase / Q000037:antagonists & inhibitors / Q000378:metabolism*; D002265:Carboxylic Ester Hydrolases / Q000037:antagonists & inhibitors / Q000378:metabolism*; D002648:Child; D002675:Child, Preschool; D005260:Female; D019382:Human Growth Hormone / Q000494:pharmacology; D006801:Humans; D006868:Hydrolysis; D007223:Infant; D007231:Infant, Newborn; D000077146:Irinotecan; D008099:Liver / Q000187:drug effects / Q000201:enzymology*; D008297:Male; D008774:Methylphenidate / Q000378:metabolism; D051379:Mice; D008875:Middle Aged; D012727:Sex Characteristics; D013347:Subcellular Fractions / Q000201:enzymology; D055815:Young Adult
D000972:Antineoplastic Agents, Phytogenic; D019382:Human Growth Hormone; D008774:Methylphenidate; D000077146:Irinotecan; D002265:Carboxylic Ester Hydrolases; C545375:carboxylesterase 1, mouse; C474609:CES1 protein, human; C517204:CES2 protein, human; D043182:Carboxylesterase; C500145:Ces2c protein, mouse; D002166:Camptothecin